USP8 and ovarian carcinoma: In this regard, USP8 has been reported to counteract apoptosis mediated by death receptors by increasing the stability of FLIPS95 and this is consistent with enhanced cisplatin-induced activation of caspase 8 following USP8 knockdown in ovarian carcinoma cells 90.